共 213 条
[1]
Lakkireddy D(2020)Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force Heart Rhythm 17 e233-480
[2]
Simovic S(2022)The use of remote monitoring of cardiac implantable devices during the COVID-19 pandemic: an EHRA physician survey Europace 24 473-237
[3]
Providencia R(2005)Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med. 352 225-883
[4]
Barra S(2002)Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med. 346 877-2078
[5]
Kircanski B(2000)Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials Eur Heart J 21 2071-1583
[6]
Guerra JM(1997)A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med. 337 1576-754
[7]
Conte G(2000)Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH) Circulation 102 748-1302
[8]
Duncker D(2000)Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 101 1297-332
[9]
Marijon E(2010)Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial Circulation 122 325-1189
[10]
Anic A(2011)The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts J Am Coll Cardiol. 57 1181-105